Trial Condition(s):

Lower-Extremity Peripheral Artery Disease (LE-PAD)

Using the French COPART registry database this study gathers French real life data of patients suffering from a health condition where narrowed arteries reduce blood flow in the part of the body from the hip to the toes

Bayer Identifier:

19885

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The aim of the study is to generate French real life data of patients suffering from a health condition where narrowed arteries reduce blood flow in the part of the body from the hip to the toes (Lower extremity peripheral artery disease, LE-PAD). By using real life data included in the French COPART registry database investigators want to learn more about the characteristics of this patient population and estimate the rate of complications such as heart disease, bleeding, amputation.

Inclusion Criteria
- Age ≥ 18 years
- Referred to the hospital specifically for management of clinical LE-PAD of atherosclerotic origin
- Consent to participate into the study
Exclusion Criteria
- Follow-up considered improbable 
- Arterial occlusive disease not related to atherosclerosis (endofibrosis, inflammatory arterial disease, Buerger´s disease, entrapment syndromes, etc.)
- Acute ischema without lower-limb atherosclerosis (embolic)
- patients refusing to participate

Trial Summary

Enrollment Goal
2513
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Xarelto (Rivaroxaban, BAY59-7939)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many locations, France

Status
Completed
 

Trial Design